IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,175 | -35.4% | 18,500 | 0.0% | 0.00% | – |
| Q2 2023 | $130,240 | -30.8% | 18,500 | -39.9% | 0.00% | – |
| Q1 2023 | $188,188 | -38.1% | 30,800 | -2.8% | 0.00% | -100.0% |
| Q3 2022 | $304,000 | -65.5% | 31,700 | -60.3% | 0.00% | 0.0% |
| Q2 2022 | $882,000 | -1.0% | 79,880 | +49.3% | 0.00% | 0.0% |
| Q1 2022 | $891,000 | -13.1% | 53,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,025,000 | +56.7% | 53,500 | +101.8% | 0.00% | 0.0% |
| Q3 2021 | $654,000 | -54.6% | 26,505 | -52.2% | 0.00% | 0.0% |
| Q2 2021 | $1,442,000 | -30.8% | 55,425 | -15.8% | 0.00% | -50.0% |
| Q1 2021 | $2,084,000 | -68.0% | 65,816 | -53.1% | 0.00% | -66.7% |
| Q4 2020 | $6,509,000 | +39.1% | 140,280 | -1.3% | 0.01% | +20.0% |
| Q3 2020 | $4,678,000 | -18.7% | 142,088 | -32.2% | 0.01% | -28.6% |
| Q2 2020 | $5,752,000 | +14.9% | 209,551 | +25.3% | 0.01% | 0.0% |
| Q1 2020 | $5,005,000 | -13.7% | 167,208 | -20.2% | 0.01% | +40.0% |
| Q4 2019 | $5,801,000 | +143.2% | 209,579 | +59.6% | 0.01% | +150.0% |
| Q3 2019 | $2,385,000 | -66.8% | 131,332 | -55.2% | 0.00% | -71.4% |
| Q2 2019 | $7,194,000 | +28.7% | 293,403 | -50.1% | 0.01% | +16.7% |
| Q1 2019 | $5,588,000 | +30.0% | 587,595 | +20.9% | 0.01% | +20.0% |
| Q4 2018 | $4,300,000 | -59.6% | 485,924 | -48.6% | 0.01% | -50.0% |
| Q3 2018 | $10,637,000 | +17.3% | 945,441 | +33.5% | 0.01% | +11.1% |
| Q2 2018 | $9,066,000 | +201.2% | 708,279 | +297.6% | 0.01% | +200.0% |
| Q1 2018 | $3,010,000 | +97.0% | 178,126 | -6.7% | 0.00% | +200.0% |
| Q4 2017 | $1,528,000 | +1.4% | 190,975 | -1.8% | 0.00% | 0.0% |
| Q3 2017 | $1,507,000 | +5.2% | 194,422 | -0.2% | 0.00% | 0.0% |
| Q2 2017 | $1,432,000 | – | 194,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |